breast cancer
PulseAugur coverage of breast cancer — every cluster mentioning breast cancer across labs, papers, and developer communities, ranked by signal.
- 2026-08-18 research_milestone Scientists utilized an AI tool to analyze breast cancer tissue, revealing new insights into disease progression. source
4 day(s) with sentiment data
-
Mammogen to launch $500 RNA blood test for breast cancer detection
Mammogen is developing a $500 RNA blood test aimed at detecting breast cancer in women with dense breasts. CEO Elizabeth Cormier-May plans to offer the test directly to consumers, supported by a Series A funding round l…
-
New K-CLUE framework enables annotation-free Ki67 cell typing in cancer images
A new framework called K-CLUE has been developed for analyzing Ki67 cell typing in breast cancer images, utilizing frozen pretrained visual representations for annotation-free analysis. This method segments nuclei, enco…
-
AI framework visualizes cancer care team dynamics and survival risk
Researchers have developed a visual analytics framework to better understand how care team dynamics in cancer treatment evolve over time and impact patient survival risk. This system uses electronic health record commun…
-
AI framework visualizes cancer care team dynamics and patient risk
Researchers have developed a visual analytics framework to model and interpret the evolving dynamics of care teams in cancer treatment. By analyzing communication data from electronic health records, they use a temporal…
-
New AI framework enhances breast cancer risk prediction using multi-view mammography
Researchers have developed FlexLMV-Net, a novel framework for predicting breast cancer risk using mammography. This system explicitly aligns tissue regions across multiple screening examinations and integrates informati…
-
Breast cancer survivor speaks out on overlooked struggles
Miranda McKeon, diagnosed with breast cancer at age 19, is sharing her experiences beyond the "strength" narrative. She is speaking out about the pain, fertility loss, and fear of recurrence associated with her diagnosis.
-
AI model predicts breast cancer therapy response using transcriptome and histopathology
Researchers have developed a novel two-stage AI model designed to predict pathological complete response (pCR) to neoadjuvant therapy in breast cancer patients. The model first infers the transcriptome from histopatholo…
-
New algorithm uses association rules for breast cancer classification
Researchers have developed a novel association rule-based classification technique to aid in the early detection of breast cancer. This method utilizes three core algorithms: Rule Generation to identify frequent pattern…
-
AI impacts healthcare and mental well-being, aiding cancer risk assessment and fueling anxiety
Artificial intelligence is increasingly being used in healthcare, with a new tool from the New York Times enabling women to assess their breast cancer risk. Concurrently, the growing prevalence of AI is contributing to …
-
New Gauss-Newton method optimizes hyperparameters for AI models
Researchers have developed a novel multi-objective hyperparameter optimization method based on a damped Gauss-Newton approach. This technique treats hyperparameter tuning as a numerical optimization problem, estimating …
-
AI model predicts personalized chemosensitivity for breast cancer treatment
Researchers have developed a causal multi-modal AI model designed to predict individual patient chemosensitivity for breast cancer treatment. This AI approach utilizes routinely collected pathology and clinical data to …
-
New TACTIC framework enhances MRI diagnosis with clinical data prompts
Researchers have developed TACTIC, a novel prompt-based multimodal framework designed to integrate whole-body MRI (WB-MRI) with structured clinical data for improved disease diagnosis. This approach, detailed in an arXi…
-
AI detects heart disease in mammograms; Zara launches UK budget brand; OpenAI exec changes
A new study suggests that AI can detect heart disease in women by analyzing mammograms, potentially allowing for simultaneous screening for both breast cancer and cardiovascular issues. Separately, the owner of Zara, In…
-
AI analyzes mammograms to detect heart disease in women
Researchers have developed an AI model capable of detecting heart disease in women by analyzing routine mammograms. This breakthrough could transform breast cancer screening into a dual-purpose tool, identifying cardiov…
-
Deep learning models show promise for label-efficient cancer diagnosis
This research paper explores three learning environments—supervised, semi-supervised, and self-supervised learning—for efficient cancer diagnosis using deep learning models. The study evaluated Residual Network-50, Visu…
-
On-device AI system developed for breast cancer multidisciplinary team meetings
Researchers have developed an on-device AI system designed to assist in breast cancer multidisciplinary team meetings. This system utilizes open-source Automatic Speech Recognition (ASR) and Large Language Models (LLMs)…
-
AI tool CenSegNet reveals new insights into breast cancer progression
Scientists have developed an AI tool called CenSegNet that can analyze centrosome abnormalities in breast cancer tissue with unprecedented detail. This breakthrough, published in Nature Communications, allows for single…
-
AI models match human experts in scientific research appraisal
A new arXiv paper demonstrates that large language models can match human experts in extracting and critically appraising information from scientific publications on microbial oncogenesis. Researchers benchmarked models…
-
New Bayesian network method improves cancer prognosis modeling
A new research paper published on arXiv proposes a method called the Survival-Aware Bayesian network to improve clinical prognostic modeling. This approach addresses the limitations of binarizing survival outcomes, a co…
-
Oncotype DX leads breast cancer recurrence risk prediction with gene expression assays
The Oncotype DX test is a widely used gene expression assay that helps predict breast cancer recurrence risk and potential benefit from chemotherapy. It is part of a broader category of molecular recurrence scores, incl…